Pages that link to "Q38475358"
Jump to navigation
Jump to search
The following pages link to Theragnostic imaging for radiation oncology: dose-painting by numbers (Q38475358):
Displaying 50 items.
- Validation of functional imaging as a biomarker for radiation treatment response (Q26823165) (← links)
- Imaging techniques for tumour delineation and heterogeneity quantification of lung cancer: overview of current possibilities (Q27025204) (← links)
- Positron emission tomography to assess hypoxia and perfusion in lung cancer (Q27026940) (← links)
- Towards multidimensional radiotherapy: key challenges for treatment individualisation. (Q27687218) (← links)
- Exploring the role of cancer stem cells in radioresistance (Q28282037) (← links)
- Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. (Q33515391) (← links)
- Physical radiotherapy treatment planning based on functional PET/CT data (Q33646064) (← links)
- Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes (Q33689901) (← links)
- New challenges in high-energy particle radiobiology (Q33782346) (← links)
- Diffusion Magnetic Resonance Imaging in Cancer Patient Management (Q33831272) (← links)
- A phantom model demonstration of tomotherapy dose painting delivery, including managed respiratory motion without motion management (Q33921434) (← links)
- PET imaging for the quantification of biologically heterogeneous tumours: measuring the effect of relative position on image-based quantification of dose-painting targets (Q34140212) (← links)
- On Voxel based Iso-Tumor Control Probabilty and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity Modulated Radiotherapy. (Q34399725) (← links)
- Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study (Q34409655) (← links)
- Feasibility and sensitivity study of helical tomotherapy for dose painting plans (Q34578403) (← links)
- Feasibility of dose painting using volumetric modulated arc optimization and delivery. (Q34662439) (← links)
- Innovations in image-guided radiotherapy. (Q34717651) (← links)
- Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma (Q35504767) (← links)
- Imaging oxygenation of human tumours (Q35676947) (← links)
- Spatio-Temporal Dynamics of Hypoxia during Radiotherapy (Q35745894) (← links)
- Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptake (Q35747345) (← links)
- Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption? (Q36066409) (← links)
- Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients (Q36104455) (← links)
- Kill-painting of hypoxic tumours in charged particle therapy. (Q36310285) (← links)
- The physical basis and future of radiation therapy (Q36324863) (← links)
- Spatially resolved regression analysis of pre-treatment FDG, FLT and Cu-ATSM PET from post-treatment FDG PET: an exploratory study (Q36374058) (← links)
- Changes in Tumor Biology During Chemoradiation of Cervix Cancer Assessed by Multiparametric MRI and Hypoxia PET. (Q36379633) (← links)
- Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan (Q36410337) (← links)
- A segmentation framework towards automatic generation of boost subvolumes for FDG-PET tumors: a digital phantom study (Q36413240) (← links)
- Multi-observation PET image analysis for patient follow-up quantitation and therapy assessment (Q36437342) (← links)
- Randomized controlled trials in health technology assessment: overkill or overdue? (Q36516936) (← links)
- From anatomical to biological target volumes: the role of PET in radiation treatment planning (Q36657385) (← links)
- Short-course PET based simultaneous integrated boost for locally advanced cervical cancer (Q36679179) (← links)
- Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. (Q36695654) (← links)
- Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes (Q36711387) (← links)
- Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions (Q36747219) (← links)
- The impact of functional imaging on radiation medicine (Q36908974) (← links)
- Is there room for combined modality treatments? Dosimetric comparison of boost strategies for advanced head and neck and prostate cancer (Q36979680) (← links)
- Detoxification of gold nanorods by treatment with polystyrenesulfonate. (Q37033845) (← links)
- Evaluating target cold spots by the use of tail EUDs (Q37244418) (← links)
- On the impact of functional imaging accuracy on selective boosting IMRT (Q37332199) (← links)
- Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer (Q37333035) (← links)
- On the importance of prompt oxygen changes for hypofractionated radiation treatments. (Q37376797) (← links)
- Functional MRI for radiotherapy dose painting (Q37467524) (← links)
- Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans (Q37478420) (← links)
- Pharmacokinetic modeling of a novel hypoxia PET tracer [18F]HX4 in patients with non-small cell lung cancer (Q37496776) (← links)
- PET-CT for response assessment and treatment adaptation in head and neck cancer (Q37708526) (← links)
- Reproducibility of four-dimensional computed tomography-based lung ventilation imaging (Q37710105) (← links)
- Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc (Q37719626) (← links)
- Imaging in radiation oncology: a perspective. (Q37736122) (← links)